UCL70805F not checked

UTC Therapeutics Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
1 active
1 in total
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
CD70-positive Advanced Renal Clear Cell Carcinoma
Main trialPhase 1
“This is a single-arm, open-label, exploratory clinical study to evaluate the safety and preliminary efficacy of UCL70805F in patients with CD70-positive advanced renal clear cell carcinoma.”In the company’s words, NCT07500805 on ClinicalTrials.gov

Other drugs for CD70-positive Advanced Renal Clear Cell Carcinoma

All 126 drugs for CD70-positive Advanced Renal Clear Cell Carcinoma

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Not yet recruiting 1 May 2028 UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026

Follow UCL70805F

Following is part of Solo: you see every change to UCL70805F the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in